טוען...
Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause
OBJECTIVE: Cancer-related cognitive impairment (CRCI) is commonly reported following the administration of cancer treatment. Current longitudinal studies, primarily in women with breast cancer, suggest that up to 35% to 60% of patients exhibit persistent CRCI (pCRCI) following completion of chemothe...
שמור ב:
| הוצא לאור ב: | Psychooncology |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993087/ https://ncbi.nlm.nih.gov/pubmed/29904964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pon.4796 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|